Guru Ownership Trend
Guru Analysis for Indivior Pharmaceuticals, Inc. (INDV)
Indivior Pharmaceuticals, Inc. (INDV), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $276.77 M.
Top institutional holders include Howard Marks and Steven Cohen.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $277.46 M net inflow during the quarter.
Recent activity highlights Steven Cohen who dramatically increased their stake. Conversely, Joel Greenblatt reduced exposure by 44.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Indivior Pharmaceuticals, Inc. (INDV)
Major holders include Howard Marks ($251.4 M), Steven Cohen ($51.31 M), Cliff Asness ($8.77 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 7.75 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $277.46 M, with 3 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited INDV. The total reported sell value was $22.63 M.
Yes, 1 managers opened new positions in INDV, and 2 increased their existing holdings. The total reported buy value was $300.09 M.